WINNERS & LOSERS: Allergy Therapeutics shares plunge on AIM exit plan
3rd Nov 2026 10:44
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More
| Price | 142.50p on 06-11-2026 at 05:12:26 |
|---|---|
| Change | 0.00p 0% |
| Buy | 142.00p |
| Sell | 139.00p |
| Last Trade: | Sell 6,299.00 at 142.50p |
| Day's Volume: | 0 |
| Last Close: | 142.50p |
| Open: | 0.00p |
| ISIN: | GB0008475088 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 77.00p - 164.50p |
| Market Capitalisation: | £93.74m |
| VWAP: | 0.00p |
| Shares in Issue: | 65.78m |
Robert Walters (RWA) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 6,299 | 142.50p | Uncrossing Trade |
16:35:23 - 05-Nov-26 |
| Buy* | 2 | 142.00p | Automatic Execution |
16:28:00 - 05-Nov-26 |
| Unknown* | 440 | 141.00p | SI Trade |
16:05:51 - 05-Nov-26 |
| Sell* | 56 | 141.50p | Automatic Execution |
15:57:18 - 05-Nov-26 |
| Sell* | 20 | 141.50p | SI Trade |
15:45:33 - 05-Nov-26 |
| Buy* | 18 | 144.00p | Ordinary |
15:32:36 - 05-Nov-26 |
| Sell* | 2,796 | 144.00p | Automatic Execution |
15:31:36 - 05-Nov-26 |
| Sell* | 1,036 | 144.00p | Automatic Execution |
15:03:40 - 05-Nov-26 |
| Sell* | 250 | 145.1525p | Ordinary |
14:35:41 - 05-Nov-26 |
| Sell* | 250 | 145.6297p | Ordinary |
14:32:45 - 05-Nov-26 |
Robert Walters (RWA) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 14th Oct 2026 5:53 pm | RNS | Block Listing Six Monthly Return |
| 14th Oct 2026 7:00 am | RNS | Q3 2026 Trading Update |
| 23rd Sep 2026 4:15 pm | RNS | Holding(s) in Company |
| 23rd Sep 2026 8:45 am | RNS | Holding(s) in Company |
| 30th Jul 2026 7:00 am | RNS | 2026 Half-Year Results |
| 15th Jul 2026 4:09 pm | RNS | Holding(s) in Company |
| 14th Jul 2026 7:00 am | RNS | Q2 2026 Trading Update |
| 25th Jun 2026 10:18 am | RNS | Holding(s) in Company |
| 14th May 2026 9:24 am | RNS | Director/PDMR Shareholding |
| 13th May 2026 10:40 am | RNS | Director/PDMR Shareholding |